Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126409221 | 12640922 | 1 | I | 20160803 | 20160810 | 20160810 | EXP | IT-GLAXOSMITHKLINE-IT2016GSK114121 | GLAXOSMITHKLINE | 47.00 | YR | M | Y | 0.00000 | 20160810 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126409221 | 12640922 | 1 | PS | BUPROPION. | BUPROPION | 1 | U | 18644 | |||||||||||
| 126409221 | 12640922 | 2 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | U | 0 | |||||||||||
| 126409221 | 12640922 | 3 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126409221 | 12640922 | 1 | Depression |
| 126409221 | 12640922 | 2 | Depression |
| 126409221 | 12640922 | 3 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126409221 | 12640922 | OT |
| 126409221 | 12640922 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126409221 | 12640922 | Basilar artery occlusion | |
| 126409221 | 12640922 | Cerebrovascular accident | |
| 126409221 | 12640922 | Depressed level of consciousness | |
| 126409221 | 12640922 | Dysarthria | |
| 126409221 | 12640922 | Hemiplegia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |